Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 7/20 | 0.44 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.43 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL969822 | 1.00 | P2RY10 (0.44) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL7571747 | 1.00 | P2RY10 (0.44) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL7570925 | 0.97 | S1PR1 (0.47) | P2RY10GPR34S1PR1 | |
| SCHEMBL5312425 | 0.94 | ALDH1A1 (0.48) | TRPV1S1PR1 | |
| SCHEMBL226745 | 0.94 | PLA2G2C (0.43) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL17144721 | 0.94 | PLA2G2C (0.43) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL3963403 | 0.94 | PLA2G2C (0.43) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL19410782 | 0.94 | PLA2G2C (0.43) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL37519 | 0.94 | PLA2G2C (0.43) | P2RY10GPR34LPAR3LPAR1ENPP2 | |
| SCHEMBL7573946 | 0.91 | FABP3 (0.42) | P2RY10GPR34LPAR3LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3302436-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | The General Hospital Corporation (US) | 2018-04-11 | — | — | EP | claimed |
| WO-2016191556-A1 | LIPOSOMAL NANOCONSTRUCTS AND METHODS OF MAKING AND USING THE SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2016-12-01 | — | — | WO | claimed |
| EP-4633673-A1 | MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE | Sanofi Pasteur Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| WO-2024126809-A1 | MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE | SANOFI (FR) | 2024-06-20 | — | — | WO | disclosed |